BnH-015B
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BnH-015B, covering 2025-01-07 to 2025-01-07. Get the full timeline:
Most recent: Clinical Trial Update: BnH-015B Clinical Trial in Moderate Alzheimer's Disease [Phase 1]